Vigene Biosciences Sees Growth Through a Commitment to Gene Therapy and Rare Diseases

Published on :

About a year ago, BioBuzz attended the grand opening of Vigene Biosciences (Vigene) brand new headquarters in Rockville, Maryland. It was a fantastic day for Vigene, the BioHealth Capital Region (BHCR), and for the patients and families of people suffering from cancer and rare genetic diseases.

Vigene Biosciences Plans Major Expansion in Maryland, Adding up to 245 Jobs

Vigene Biosciences Expansion 245 New Jobs
Published on :

Vigene, a gene therapy development company, said it intends to lease a 52,000 square-foot manufacturing space at 14200 Shady Grove Road that will nearly double the company’s existing manufacturing footprint. The new space is in addition to its existing headquarters, R&D, and manufacturing locations that opened in Rockville last year. The additional space from the new facility will allow the company to expand its current headcount of 125 by the addition of 245 more employees.

End of Year Update: 2020 Life Science Venture Capital Funding Roundup in the BioHealth Capital Region

Published on :

This has certainly been a year unlike any other for BioHealth Capital Region (BHCR) life science companies of all sizes and kinds. Just a few months into 2020, the coronavirus pandemic swept the region, seriously disrupting, albeit temporarily, the best laid plans of aspiring founders, entrepreneurs, emerging startups, pre-clinical and more established, larger biohealth organizations in Virginia, Washington, D.C. and Maryland.

2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region

Published on :

2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region  BioHealth Companies raised more than $178M in the first half of 2020 June 9, 2020 This [….]